Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
88(4):309-20
Treatment with SR18662 significantly reduces growth and proliferation of CRC cells
3-bis(hexadecanoyloxy)propoxy]({2-[(2S)-2-[(4R)-4-carbamoyl-4-[(2S)-2-[(2R)-2-{[(2R
CAS Number: 1240299-33-5
NVP-BKM120 Hydrochloride - CAS# 1312445-63-8 Catalog No.:M10296-2 88(4):309-20Buparlisib, also known as BKM120, is an orally bioavailable specific oral inhibitor of the pan class I phosphatidylinositol 3 kinase (PI3K) family of lipid kinases with potential antineoplastic activity. PI3K inhibitor BKM120 specifically inhibits class I PIK3 in the PI3K AKT kinase (or protein kinase B) signaling pathway in an ATP competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol 3,4,5 trisphosphate